1. Home
  2. ARAY vs BMN Comparison

ARAY vs BMN Comparison

Compare ARAY & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARAY
  • BMN
  • Stock Information
  • Founded
  • ARAY 1990
  • BMN 2020
  • Country
  • ARAY United States
  • BMN United States
  • Employees
  • ARAY N/A
  • BMN 19800
  • Industry
  • ARAY Medical/Dental Instruments
  • BMN Trusts Except Educational Religious and Charitable
  • Sector
  • ARAY Health Care
  • BMN Finance
  • Exchange
  • ARAY Nasdaq
  • BMN Nasdaq
  • Market Cap
  • ARAY 180.0M
  • BMN 154.6M
  • IPO Year
  • ARAY 2007
  • BMN N/A
  • Fundamental
  • Price
  • ARAY $2.24
  • BMN $25.44
  • Analyst Decision
  • ARAY Strong Buy
  • BMN
  • Analyst Count
  • ARAY 1
  • BMN 0
  • Target Price
  • ARAY $9.00
  • BMN N/A
  • AVG Volume (30 Days)
  • ARAY 669.1K
  • BMN 29.9K
  • Earning Date
  • ARAY 01-29-2025
  • BMN 01-01-0001
  • Dividend Yield
  • ARAY N/A
  • BMN 4.66%
  • EPS Growth
  • ARAY N/A
  • BMN N/A
  • EPS
  • ARAY N/A
  • BMN N/A
  • Revenue
  • ARAY $444,204,000.00
  • BMN N/A
  • Revenue This Year
  • ARAY $6.64
  • BMN N/A
  • Revenue Next Year
  • ARAY $5.69
  • BMN N/A
  • P/E Ratio
  • ARAY N/A
  • BMN N/A
  • Revenue Growth
  • ARAY N/A
  • BMN N/A
  • 52 Week Low
  • ARAY $1.40
  • BMN $21.51
  • 52 Week High
  • ARAY $2.99
  • BMN $25.59
  • Technical
  • Relative Strength Index (RSI)
  • ARAY 60.03
  • BMN 49.12
  • Support Level
  • ARAY $2.04
  • BMN $25.32
  • Resistance Level
  • ARAY $2.34
  • BMN $25.78
  • Average True Range (ATR)
  • ARAY 0.15
  • BMN 0.30
  • MACD
  • ARAY 0.03
  • BMN -0.02
  • Stochastic Oscillator
  • ARAY 82.76
  • BMN 20.05

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest

BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.

Share on Social Networks: